Login Issues for Existing Institutions on New PCI Portal
To expedite the resolution of these issues, institutions experiencing login problems are requested to promptly fill out a Google form. The form is designed to collect necessary information for a swift resolution of the login concerns.
CDSCO Revises Drug Alert for May 2022
CDSCO has purported Omeprazole (Delayed-Release) and Domperidone (Sustained Release) Capsules as spurious. This drug is purported to be manufactured by Dr. Reddys Laboratories Ltd., Village Mauja Thana, Baddi173205, Dist. Solan, Himachal Pradesh. However, the actual manufacturer (as per label claim) has stated that the impugned batch of the product has not been manufactured by them and that it is a spurious drug.
Drug Alert List for November 2023
A total of 1197 samples were tested by the CDSCO. Based on the samples tested, CDSCO has found a total of 64 drugs, medical devices and cosmetics that are identified as being deficient.
Updated Bank Account Details for National Hands-on Training Programme on Biogas Technology
The Ministry of New and Renewable Energy (MNRE) has published a corrigendum on the previous announcement regarding the registration process for the National Hands-on Training Programme on Biogas Technology and its Implementation. This corrigendum is issued by the Sardar Swaran Singh National Institute of Bio-Energy. The present corrigendum has updated the bank account details for NEFT/IMPS transactions.
Draft Guidelines on IFSCA (Assets, Liabilities, and Solvency Margin) Regulations 2023
These guidelines further specify the regulatory requirements towards maintenance of capital and solvency margins for transacting insurance business by IIOs registered with the Authority whether set up in an incorporated or in unincorporated form in the IFSC.
Frequently Asked Questions (FAQs) on IFSC Insurance Office
IFSCA vide circular dated 21.12.2023 has issued Frequently Asked Questions (FAQs) on IFSC Insurance Office (updated as on December 13, 2023). The revised Frequently Asked Questions provides clarifications regarding all IFSCA regulations.
Consultation paper on proposed Guidelines on IFSCA(Assets, Liabilities, and Solvency Margin of General, Health and Re-insurance business) Regulations, 2023
In addition to the forms, IIOs are required to submit a quarterly certificate demonstrating their solvency and compliance with capital requirements. For IIOs incorporated in an IFSC, this certificate must be signed by the appointed actuary and the principal officer. For unincorporated IIOs, the signing responsibility falls to the actuary or the principal officer of the parent entity. This certification process ensures that the IIOs maintain sufficient capital buffers and are solvent, which is crucial for policyholder protection.
Report of the Working Group on Direct Listing of Listed Indian Companies on IFSC Exchanges
The tax on dividend may be reduced to 10% for shareholders in IFSC. This would be in line with the DR framework.
